Sarah Schlesinger

Insider Reports History

Entity
Individual
Location
C/O Ariad Pharmaceuticals, 26 Landsdowne Street, Cambridge, MA
Signature
/s/ Sarah Schlesinger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sarah Schlesinger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Innoviva, Inc. Director Common Stock 119K $1.91M $16.13 Jun 17, 2024 Direct
Armata Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 94K Mar 14, 2024 Direct
Innoviva, Inc. Director Non-statutory Stock Option 30K Jun 17, 2024 Direct

Insider Reports Filed by Sarah Schlesinger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INVA Innoviva, Inc. Jun 17, 2024 2 $0 4 Jun 20, 2024 Director
ARMP Armata Pharmaceuticals, Inc. Mar 14, 2024 2 $0 4 Mar 18, 2024 Director
ARMP Armata Pharmaceuticals, Inc. Dec 21, 2023 1 $0 4 Dec 26, 2023 Director
INVA Innoviva, Inc. May 22, 2023 2 $0 4 May 24, 2023 Director
INVA Innoviva, Inc. Apr 25, 2022 2 $0 4 Apr 27, 2022 Director
ARMP Armata Pharmaceuticals, Inc. Apr 13, 2022 1 $0 4 Apr 15, 2022 Director
ARMP Armata Pharmaceuticals, Inc. Jun 7, 2021 1 $0 4 Jun 9, 2021 Director
INVA Innoviva, Inc. May 14, 2021 1 $0 4 May 20, 2021 Director